Labdoor
Growth Stage
Labdoor tests and reviews the purity and accuracy of 1,000+ supplements and CBD
Analytics
Raised: $182,911
Aggregate Commitments $
Platform
Wefunder
Start Date
08/11/2022
Close Date
04/30/2023
Min. Goal
$50,000
Max. Goal
$1,070,000
Min. Investment
$100
Security Type
SAFE
Funding Type
RegCF
Series
Series A
Valuation Cap
$20,000,000
Discount Rate
20%
Rolling Commitments $
Status
Active
Reporting Date
09/25/2022
Days Remaining
217
% of Min. Goal
366%
% of Max. Goal
17%
Likelihood of Max
Avg. Daily Raise
$4,065
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
San Francisco, California
Industry
Healthcare & Pharmaceuticals
Tech Sector
Foodtech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
Low
Labdoor, with a valuation of $20 million, is raising funds on Wefunder. The company provides expert scientific reviews of consumer health products. It tests and reviews the purity and labels accuracy of over 1,000 products, including vitamins, supplements, and CBD. The certifications provided by Labdoor allow companies to compete with competitors on product quality rather than marketing hype. Neil Thanedar, Rafael Ferreira, and Helton Souza founded Labdoor in April 2012. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1,070,000. The campaign proceeds will be used for hiring a salesperson, hiring a researcher, marketing, research and development, and general and administrative costs.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$412,034 |
$473,156 |
|
COGS |
$74,683 |
$41,360 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-66,084 |
$134,457 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$8,661 |
$104,704 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$11,773 |
$107,523 |
|
Short-Term Debt |
$46,962 |
$55,362 |
|
Long-Term Debt |
$596,629 |
$617,895 |
|
Total Liabilities |
$643,591 |
$673,257 |
Financials as of: 08/11/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Analyst Report
Pending Review